Safety of 9-valent human papillomavirus vaccine administered to males and females in routine use

CONCLUSIONS: We did not identify new safety concerns related to HPV9. The results are consistent with the HPV9 safety profile as established from previous studies/surveillance.REGISTRATION: European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (EUPAS13151, protocol V503-028).PMID:36396513 | DOI:10.1016/j.vaccine.2022.11.009

Source: Vaccine - November 17, 2022 Category: Allergy & Immunology Authors: John Hansen Arnold Yee Ned Lewis Se Li Christine Velicer Patricia Saddier Nicola P Klein Source Type: research